Endoscopic resection (endoscopic submucosal dissection/endoscopic mucosal resection) for superficial Barrett's esophageal cancer

Digestive Endoscopy

Volumn 25, Issue SUPPL.1, 2013, Pages 20-28

  Koike, Tomoyuki ^a   Nakagawa, Kenichiro ^a   Iijima, Katsunori ^a   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

endoscopic mucosal resection (EMR); endoscopic submucosal dissection (ESD); superficial Barrett's esophageal cancer

Indexed keywords

PREDNISOLONE; TRANILAST; TRIAMCINOLONE;

BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SURGERY; CHROMOENDOSCOPY; CORTICOSTEROID THERAPY; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SUBMUCOSAL DISSECTION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS DYSPLASIA; HUMAN; JAPAN; NARROW BAND IMAGING; RADIOFREQUENCY ABLATION; REVIEW; TREATMENT INDICATION;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CROSS-CULTURAL COMPARISON; DISSECTION; EQUIPMENT DESIGN; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HUMANS; JAPAN; LYMPHATIC METASTASIS; MUCOUS MEMBRANE; NARROW BAND IMAGING; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME;

EID: 84874963958     PISSN: 09155635     EISSN: 14431661     Source Type: Journal    
DOI: 10.1111/den.12047     Document Type: Review

References (117)

1. Hassall E,. Barrett's esophagus: Congenital or acquired? Am. J. Gastroenterol. 1993; 88: 819-824.
2. Eisen GM, Sandler RS, Murray S, Gottfried M,. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am. J. Gastroenterol. 1997; 92: 27-31.
3. Haggitt RC,. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum. Pathol. 1994; 25: 982-993.
4. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK,. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994; 344: 1533-1536.
5. Chow WH, Finkle WD, McLaughlin JK, Frankl H, Ziel HK, Fraumeni JF Jr,. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 1995; 274: 474-477.
6. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR,. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104: 510-513.
7. Pohl H, Welch HG,. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J. Natl Cancer Inst. 2005; 97: 142-146.
8. Sharma P,. Clinical practice. Barrett's esophagus. N. Engl. J. Med. 2009; 361: 2548-2556.
9. Buttar NS, Wang KK, Sebo TJ, et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001; 120: 1630-1639.
10. Hongo M, Nagasaki Y, Shoji T,. Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J. Gastroenterol. Hepatol. 2009; 24: 729-735.
11. Inomata Y, Koike T, Ohara S, et al. Preservation of gastric acid secretion may be important for the development of gastroesophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status. Am. J. Gastroenterol. 2006; 101: 926-933.
12. Horii T, Koike T, Abe Y, et al. Two distinct types of cancer of different origin may be mixed in gastroesophageal junction adenocarcinomas in Japan: Evidence from direct evaluation of gastric acid secretion. Scand. J. Gastroenterol. 2011; 46: 710-719.
13. Koike T, Ohara S, Inomata Y, et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with gastroesophageal junction adenocarcinoma in Japan. Inflammopharmacology 2007; 15: 61-64.
14. Koike T, Ohara S, Shimosegawa T,. Role of gastric acid secretion in the pathogenesis of Barrett's esophageal cancer in a Japanese population. Clin. J. Gastroenterol. 2009; 2: 143-148.
15. Sampliner RE,. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameter Committee of the American College of Gastroenterology. Am. J. Gastroenterol. 1998; 93: 1028-1032.
16. Takubo K, Aida J, Sawabe M, et al. The normal anatomy around the oesophagogastric junction: A histopathologic view and its correlation with endoscopy. Best Pract. Res. Clin. Gastroenterol. 2008; 22: 569-583.
17. Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK,. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction. Gastroenterology 1999; 116: 277-285.
18. Hongo M, Shoji T,. Epidemiology of reflux disease and CLE in east Asia. J. Gastroenterol. 2003; 38 (Suppl): 25-30.
19. Azuma N, Endo T, Arimura Y, et al. Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan. J. Gastroenterol. 2000; 35: 583-592.
20. Kawano T, Kouzu T, Kawano T, et al. The prevalence of Barrett's mucosa in the Japanese (in Japanese with English abstract). Gastroenterol. Endosc. 2005; 47: 951-961.
21. Zehetner J, DeMeester SR, Ayazi S, et al. Long-term follow-up after anti-reflux surgery in patients with Barrett's esophagus. J. Gastrointest. Surg. 2010; 14: 1483-1491.
22. Hvid-Jensen F, Pedersen L, Drewes AM, et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. N. Engl. J. Med. 2011; 365: 1375-1383.
23. Wani S, Falk G, Hall M, et al. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin. Gastroenterol. Hepatol. 2011; 9: 220-227.
24. Weston AP, Sharma P, Topalovski M, Richards R, Cherian R, Dixon A,. Long-term follow-up of Barrett's high-grade dysplasia. Am. J. Gastroenterol. 2000; 95: 1888-1893.
25. Ramoner R, Rieser C, Bartsch G, Thurnher M,. Nordihydroguaiaretic acid blocks secretory and endocytic pathways in human dendritic cells. J. Leukoc. Biol. 1998; 64: 747-752.
26. Hameeteman W, Tytgat GN, Houthoff HJ, van den, Tweel JG,. Barrett's esophagus: Development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96: 1249-1256.
27. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ,. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993; 105: 40-50.
28. Wang KK, Sampliner RE,. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am. J. Gastroenterol. 2008; 103: 788-797.
29. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS,. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119: 333-338.
30. Takubo K, Aida J, Sawabe M, et al. Early squamous cell carcinoma of the esophagus: The Japanese viewpoint. Histopathology 2007; 51: 733-742.
31. Takubo K, Arai T, Sawabe M,. Structures of the normal esophagus and Barrett's esophagus. Esophagus 2003; 1: 37-47.
32. Takubo K, Vieth M, Aida J, et al. Differences in the definition used for esophageal and gastric diseases in different countries. Digestion 2009; 80: 248-257.
33. Konda VJ, Waxman I,. Endotherapy for Barrett's esophagus. Am. J. Gastroenterol. 2012; 107: 827-833.
34. Ortiz-Fernández-Sordo J, Parra-Blanco A, García-Varona A, et al. Endoscopic resection techniques and ablative therapies for Barrett's neoplasia. World J. Gastrointest. Endosc. 2011; 3: 171-182.
35. Koike T, Abe Y, Iijima K, et al. Diagnosis of Barrett's esophageal cancer by the normal endoscopy observation. Stom. Intest. 2011; 46: 1800-1814. (in Japanese with English abstract)
36. Gono K, Obi T, Yamaguchi M, et al. Appearance of enhanced tissue feature in narrow-band endoscopic imaging. J. Biomed. Opt. 2004; 9: 568-577.
37. Sharma P, Bansal A, Mathur S, et al. The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. Gastrointest. Endosc. 2006; 64: 167-175.
38. Kara MA, Ennahachi M, Fockens P, et al. Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett's esophagus by using narrow band imaging. Gastrointest. Endosc. 2006; 64: 155-166.
39. Curvers WL, Bohmer CJ, Mallant-Hent RC, et al. Mucosal morphology in Barrett's esophagus: Interobserver agreement and role of narrow band imaging. Endoscopy 2008; 40: 799-805.
40. Curvers WL, van den Broek FJ, Reitsma JB, et al. Systematic review of narrow-band imaging for the detection and differentiation of abnormalities in the esophagus and stomach. Gastrointest. Endosc. 2009; 69: 307-317.
41. Singh M, Bansal A, Curvers WL, et al. Observer agreement in the assessment of narrowband imaging system surface patterns in Barrett's esophagus: A multicenter study. Endoscopy 2011; 43: 745-751.
42. Herrero LA, Curvers WL, Bansal A, et al. Zooming in on Barrett oesophagus using narrow-band imaging: An international observer agreement study. Eur. J. Gastroenterol. Hepatol. 2009; 21: 1068-1075.
43. Sharma P, Marcon N, Wani S, et al. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: A prospective multicenter study. Endoscopy 2006; 38: 1206-1212.
44. Pohl J, Pech O, May A, et al. Incidence of macroscopically occult neoplasias in Barrett's esophagus: Are random biopsies dispensable in the era of advanced endoscopic imaging? Am. J. Gastroenterol. 2010; 105: 2350-2356.
45. Stolte M, Kirtil T, Oellig F, et al. The pattern of invasion of early carcinomas in Barrett's esophagus is dependent on the depth of infiltration. Pathol. Res. Pract. 2010; 206: 300-304.
46. Bergman JJ,. Endoscopic treatment of high-grade intraepithelial neoplasia and early cancer in Barrett oesophagus. Best Pract. Res. Clin. Gastroenterol. 2005; 19: 889-907.
47. Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions: Esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest. Endosc. 2003; 58: S3-43.
48. Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 2005; 37: 570-578.
49. Wani S, Sayana H, Sharma P,. Endoscopic eradication of Barrett's esophagus. Gastrointest. Endosc. 2010; 71: 147-166.
50. Feith M, Stein HJ, Siewert JR,. Pattern of lymphatic spread of Barrett's cancer. World J. Surg. 2003; 27: 1052-1057.
51. Zemler B, May A, Ell C, Stolte M,. Early Barrett's carcinoma: The depth of infiltration of the tumour correlates with the degree of differentiation, the incidence of lymphatic vessel and venous invasion. Virchows Arch. 2010; 456: 609-614.
52. Vieth M, Ell C, Gossner L, May A, Stolte M,. Histological analysis of endoscopic resection specimens from 326 patients with Barrett's esophagus and early neoplasia. Endoscopy 2004; 36: 776-781.
53. Buskens CJ, Westerterp M, Lagarde SM, Bergman JJ, ten, Kate FJ, van, Lanschot JJ,. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest. Endosc. 2004; 60: 703-710.
54. Westerterp M, Koppert LB, Buskens CJ, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch. 2005; 446: 497-504.
55. Ancona E, Rampado S, Cassaro M, et al. Prediction of lymph node status in superficial esophageal carcinoma. Ann. Surg. Oncol. 2008; 15: 3278-3288.
56. Manner H, May A, Pech O, et al. Early Barrett's carcinoma with 'low-risk' submucosal invasion: Long-term results of endoscopic resection with a curative intent. Am. J. Gastroenterol. 2008; 103: 2589-2597.
57. Waxman I, Konda VJ,. Mucosal ablation of Barrett esophagus. Nat. Rev. Gastroenterol. Hepatol. 2009; 6: 393-401.
58. Tada M, Murata M, Murakami F, et al. Development of the strip-off biopsy. Gastroenterol. Endosc. 1984; 26: 833-839.
59. Makuuchi H, Machimura T, Soh Y, et al. Endoscopic mucosectomy for mucosal carcinomas in the esophagus. Jpn. J. Surg. Gastroenterol. 1991; 24: 2599-2603.
60. Inoue H, Endo M, Takeshita K, et al. Endoscopic resection of early-stage esophageal cancer. Surg. Endosc. 1991; 5: 59-62.
61. Abrams JA, Fedi P, Vakiani E, Hatefi D, Remotti HE, Lightdale CJ,. Depth of resection using two different endoscopic mucosal resection techniques. Endoscopy 2008; 40: 395-399.
62. May A, Gossner L, Behrens A, et al. A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest. Endosc. 2003; 58: 167-175.
63. Peters FP, Kara MA, Curvers WL, et al. Multiband mucosectomy for endoscopic resection of Barrett's esophagus: Feasibility study with matched historical controls. Eur. J. Gastroenterol. Hepatol. 2007; 19: 311-315.
64. Kantsevoy SV, Adler DG, Conway JD, et al. Endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest. Endosc. 2008; 68: 11-18.
65. Inoue H, Minami H, Kaga M, Sato Y, Kudo SE,. Endoscopic mucosal resection and endoscopic submucosal dissection for esophageal dysplasia and carcinoma. Gastrointest. Endosc. Clin. N. Am. 2010; 20: 25-34.
66. Wang KK, Prasad G, Tian J,. Endoscopic mucosal resection and endoscopic submucosal dissection in esophageal and gastric cancers. Curr. Opin. Gastroenterol. 2010; 26: 453-458.
67. Pech O, Behrens A, May A, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008; 57: 1200-1206.
68. Nijhawan PK, Wang KK,. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest. Endosc. 2000; 52: 328-332.
69. Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000; 118: 670-677.
70. May A, Gossner L, Pech O, et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: Acute-phase and intermediate results of a new treatment approach. Eur. J. Gastroenterol. Hepatol. 2002; 14: 1085-1091.
71. May A, Gossner L, Pech O, et al. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): Curative treatment using local endoscopic treatment techniques. Endoscopy 2002; 34: 604-610.
72. Pacifico RJ, Wang KK, Wongkeesong LM, Buttar NS, Lutzke LS,. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Clin. Gastroenterol. Hepatol. 2003; 1: 252-257.
73. Pech O, May A, Gossner L, Ell C,. Barrett's esophagus: Endoscopic resection. Gastrointest. Endosc. Clin. N. Am. 2003; 13: 505-512.
74. Behrens A, May A, Gossner L, et al. Curative treatment for high-grade intraepithelial neoplasia in Barrett's esophagus. Endoscopy 2005; 37: 999-1005.
75. Peters FP, Kara MA, Rosmolen WD, et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest. Endosc. 2005; 61: 506-514.
76. Conio M, Repici A, Cestari R, et al. Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: An Italian experience. World J. Gastroenterol. 2005; 11: 6650-6655.
77. Larghi A, Lightdale CJ, Memeo L, et al. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Gastrointest. Endosc. 2005; 62: 16-23.
78. Mino-Kenudson M, Brugge WR, Puricelli WP, et al. Management of superficial Barrett's epithelium-related neoplasms by endoscopic mucosal resection: Clinicopathologic analysis of 27 cases. Am. J. Surg. Pathol. 2005; 29: 680-686.
79. Ell C, May A, Pech O, Gossner L, et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest. Endosc. 2007; 65: 3-10.
80. Moss A, Bourke MJ, Hourigan LF, et al. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: An essential staging procedure with long-term therapeutic benefit. Am. J. Gastroenterol. 2010; 105: 1276-1283.
81. Mino-Kenudson M, Hull MJ, Brown I, et al. EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy. Gastrointest. Endosc. 2007; 66: 660-666.
82. Maish MS, DeMeester SR,. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. Ann. Thorac. Surg. 2004; 78: 1777-1782.
83. Hull MJ, Mino-Kenudson M, Nishioka NS, et al. Endoscopic mucosal resection: An improved diagnostic procedure for early gastroesophageal epithelial neoplasms. Am. J. Surg. Pathol. 2006; 30: 114-118.
84. Gotoda T,. Endoscopic resection for premalignant and malignant lesions of the gastrointestinal tract from the esophagus to the colon. Gastrointest. Endosc. Clin. N. Am. 2008; 18: 435-450.
85. Lawner P, Laurent J, Simeone F, Fink E, Rubin E,. Attenuation of ischemic brain edema by pentobarbital after carotid ligation in the gerbil. Stroke 1979; 10: 644-647.
86. Deprez PH, Bergman JJ, Meisner S, et al. Current practice with endoscopic submucosal dissection in Europe: Position statement from a panel of experts. Endoscopy 2010; 42: 853-858.
87. Oka S, Tanaka S, Kaneko I, et al. Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Gastrointest. Endosc. 2006; 64: 877-883.
88. Oyama T, Tomori A, Hotta K, et al. Endoscopic submucosal dissection of early esophageal cancer. Clin. Gastroenterol. Hepatol. 2005; 3: S67-70.
89. Yamamoto H, Kawata H, Sunada K, et al. Success rate of curative endoscopic mucosal resection with circumferential mucosal incision assisted by submucosal injection of sodium hyaluronate. Gastrointest. Endosc. 2002; 56: 507-512.
90. Yahagi N, Fujishiro M, Naomi K, et al. Endoscopic submucosal dissection for early gastric cancer using the tip of an electrosurgical snare (thin type). Dig. Endosc. 2004; 16: 34-38.
91. Oda I, Saito D, Tada M, et al. A multicenter retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer 2006; 9: 262-270.
92. Isomoto H, Shikuwa S, Yamaguchi N, et al. Endoscopic submucosal dissection for early gastric cancer: A large-scale feasibility study. Gut 2009; 58: 331-336.
93. Fujishiro M, Yahagi N, Kakushima N, et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin. Gastroenterol. Hepatol. 2006; 4: 688-694.
94. Kakushima N, Yahagi N, Fujishiro M, Kodashima S, Nakamura M, Omata M,. Efficacy and safety of endoscopic submucosal dissection for tumors of the esophagogastric junction. Endoscopy 2006; 38: 170-174.
95. Motohashi O, Nishimura K, Nakayama N, Takagi S, Yanagida N,. Endoscopic submucosal dissection (two-point fixed ESD) for early esophageal cancer. Dig. Endosc. 2009; 21: 176-179.
96. Ono S, Fujishiro M, Niimi K, et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest. Endosc. 2009; 70: 860-866.
97. Ishii N, Horiki N, Itoh T, et al. Endoscopic submucosal dissection with a combination of small-caliber-tip transparent hood and flex knife is a safe and effective treatment for superficial esophageal neoplasias. Surg. Endosc. 2010; 24: 335-342.
98. Yoshinaga S, Gotoda T, Kusano C, Oda I, Nakamura K, Takayanagi R,. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction. Gastrointest. Endosc. 2008; 67: 202-209.
99. Cao Y, Liao C, Tan A, Gao Y, Mo Z, Gao F,. Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy 2009; 41: 751-757.
100. Ishihara R, Iishi H, Uedo N, et al. Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan. Gastrointest. Endosc. 2008; 68: 1066-1072.
101. Bergman JJ,. How to justify endoscopic submucosal dissection in the Western world. Endoscopy 2009; 41: 988-990.
102. Chennat J, Waxman I,. Endoscopic treatment of Barrett's esophagus: From metaplasia to intramucosal carcinoma. World J. Gastroenterol. 2010; 16: 3780-3785.
103. Pouw RE, Seewald S, Gondrie JJ, et al. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients. Gut 2010; 59: 1169-1177.
104. Lopes CV, Hela M, Pesenti C, et al. Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma. Surg. Endosc. 2007; 21: 820-824.
105. Chennat J, Konda VJ, Ross AS, et al. Complete Barrett's eradication endoscopic mucosal resection: An effective treatment modality for high-grade dysplasia and intramucosal carcinoma-an American single-center experience. Am. J. Gastroenterol. 2009; 104: 2684-2692.
106. Peters FP, Kara MA, Rosmolen WD, et al. Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: A prospective study. Am. J. Gastroenterol. 2006; 101: 1449-1457.
107. Seewald S, Akaraviputh T, Seitz U, et al. Circumferential EMR and complete removal of Barrett's epithelium: A new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest. Endosc. 2003; 57: 854-859.
108. van Vilsteren FG, Pouw RE, Seewald S, et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: A multicentre randomised trial. Gut 2011; 60: 765-773.
109. Ezoe Y, Muto M, Horimatsu T, et al. Efficacy of preventive endoscopic balloon dilation for esophageal stricture after endoscopic resection. J. Clin. Gastroenterol. 2011; 45: 222-227.
110. Hashimoto S, Kobayashi M, Takeuchi M, et al. The efficacy of endoscopic triamcinolone injection for prevention of esophageal stricture after endoscopic submucosal dissection. Gastrointest. Endosc. 2011; 74: 1289-1393.
111. Uno K, Iijima K, Koike T, et al. A pilot study of scheduled endoscopic balloon with oral agent tranilast to improve the efficacy of stricture dilation after endoscopic submucosal dissection of the esophagus. J. Clin. Gastroenterol. 2012; 46: e76-82.
112. Yamaguchi N, Isomoto H, Nakayama T, et al. Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Gastrointest. Endosc. 2011; 73: 1115-1121.
113. Hage M, Siersema PD, Vissers KJ, et al. Molecular evaluation of ablative therapy of Barrett's oesophagus. J. Pathol. 2005; 205: 57-64.
114. Ganz RA, Utley DS, Stern RA, Jackson J, Batts KP, Termin P,. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: A phased evaluation in the porcine and in the human esophagus. Gastrointest. Endosc. 2004; 60: 1002-1010.
115. van Vilsteren FG, Bergman JJ,. Endoscopic therapy using radiofrequency ablation for esophageal dysplasia and carcinoma in Barrett's esophagus. Gastrointest. Endosc. Clin. N. Am. 2010; 20: 55-74.
116. Frantz DJ, Dellon ES, Shaheen NJ,. Radiofrequency ablation of Barrett's esophagus. Tech. Gastrointest. Endosc. 2010; 12: 100-107.
117. Herrero LA, van Vilsteren FG, Pouw RE, et al. Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett's esophagus longer than 10 cm. Gastrointest. Endosc. 2011; 73: 682-690.